AI is cool and all... but a new paper in @ScienceMagazine kind of figured out the origin of life?
The paper reports the discovery of a simple 45-nucleotide RNA molecule that can perfectly copy itself.
New quantitative blood flow assessment of gastric conduit with indocyanine green fluorescence in oesophagectomy: prospective cohort study
➡️https://t.co/FAebJMFmEt
This prospective study investigated the relationship between intraoperative indocyanine green fluorescence intensity (FI) and anastomotic leakage (AL) in 100 patients undergoing oesophagectomy with gastric conduit reconstruction. Quantitative FI measured at the end of the right gastroepiploic artery and the anastomotic line was significantly lower in patients who developed AL, with FI ≤ 90% identified as an independent predictor. The findings suggest that real-time FI assessment can help optimize anastomotic site selection and reduce AL risk.
👏👏👏Daisuke Kajiyama , Yuto Kubo , Takashi Shigeno , Kazuma Sato , Naoto Fujiwara , Hiroyuki Daiko , Takeo Fujita
#SoMe4Surgery #MedTwitter #SurgEd #Surgery
@BJSAcademy@BJSurgery@young_bjs @OUPMedicine #some4UGI #uppergi #esophagealcancer @ISDE_net@Augishealth@roux_group #ESDE @young_esde
Favorable impact of exercise and fitness on suppression of tumor growth and glucose metabolism in the experimental models of breast cancer and melanoma in mice
https://t.co/6AEpSY7kBM
Why do some patients respond better to immunotherapy? 🤔
https://t.co/mlLHWR2on0
💥 @Nature: PPP2R1A mutations linked to improved outcomes with ICB! Across cancer types, PPP2R1A-mutant tumors show:
🎯 ↑ OS & PFS after ICB
🦠 ↑ IFN-γ signalling & T-cell infiltration
▪️ Preclinical data: targeting PP2A boosts ICB & CAR-T efficacy
If a scaffold protein becomes a signal…biology tells where therapy should go next!
@OncoAlert #OncoAlertAF @OncoReporte@myESMO@_SEOM
The first deep learning A.I. health algorithm for consumers, FDA cleared in 2018, was for smartwatch diagnosis of atrial fibrillation. Look how remarkably accurate these have played out, no less picked up thousands of people at high-risk of stroke to take blood thinners
https://t.co/8tgDzO7D0X
Novartis' new malaria treatment cured 97.4% of patients – more than the current best treatment
It kills resistant parasites, too, and probably blocks transmission better than current drugs
Approval is expected next year!
🚨 New paper alert!
⚠️ Irregular polyp morphologies make segmentation in endoscopy a real challenge!
💡⬇️The Endoscopic Adaptive Transformer (EAT) uses an adaptive perception module to dynamically capture fine anatomical details and global context!
https://t.co/FGPXpvp5iy
The first UK patient to receive a @neuralink implant used a computer just by using his thoughts hours after his surgery at UCLH.
Paul, who has motor neurone disease, joined the GB-PRIME study and is now exploring use of the technology in his daily life: https://t.co/MEU1HxYB79
Editor's Note: The JAMA Network invites research submissions on #AI in clinical settings, prioritizing rigorous methodologies and validation for informed medical practice.
https://t.co/djRXO4y2lg